Item 2.02 Results of Operations and Financial Condition. On November 8th, 2021, MedAvail Holdings, Inc. ("MedAvail" or the "Company") issued a press release regarding its financial and operational results for the three months ended September 30th, 2021. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. This information is intended to be furnished under Items 2.02 and 9.01 of this Current Report on Form 8-K, including Exhibit 99.1, and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), except as shall be expressly set forth by specific reference in such a filing.




Item 7.01 Regulation FD Disclosure.
On November 8th, 2021, MedAvail hosted a conference call and webcast to discuss
the Company's financial and operational results for the three months ended
September 30th, 2021.
Additionally, attached as Exhibit 99.2 to this Current Report on Form 8-K is an
investor presentation that MedAvail may use in presentations to investors
beginning November 8, 2021.
The presentation includes a discussion of Operating Results and Adjusted EBITDA,
non-GAAP (generally accepted accounting principles) financial measures. The
presentation also includes reconciliations of those measures to the most
directly comparable financial measures calculated and presented in accordance
with GAAP.
The investor presentation attached as Exhibit 99.2 to this Current Report on
Form 8-K includes "safe harbor" language pursuant to the Private Securities
Litigation Reform Act of 1995, as amended, indicating that certain statements
contained in the slide presentation are "forward looking" rather than
historical.
The information included in this Item 7.01 and in Exhibit 99.2 shall not be
deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise
subject to the liabilities of that Section or incorporated by reference in any
filing under the Securities Act or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing. The Company
undertakes no duty or obligation to update or revise information included in
this Report or in the Exhibit 99.2.


Item 9.01 Financial Statement and Exhibits.
(d) Exhibits
 Exhibit No.      Description
99.1                MedAvail Holdings, Inc. Press Release dated November 8, 2021
99.2                MedAvail Holdings, Inc. Investor Presentation

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses